Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

Amyloid-β (Aβ) plays a central role in the pathogenesis of Alzheimer's disease (AD) and has been postulated as a potential biomarker for AD. However, there is a lack of consensus as to its suitability as an AD biomarker. The objective of this study was to determine the significance of plasma Aβ...

Full description

Bibliographic Details
Main Authors: Lui, J., Laws, S., Li, Q., Villemagne, V., Ames, D., Brown, B., Bush, A., De Ruyck, K., Dromey, J., Ellis, K., Faux, N., Foster, Jonathan, Fowlor, C., Gupta, V., Hudson, P., Laughton, K., Masters, C., Pertile, K., Rembach, A., Rimajova, M., Rodrigues, M., Rowe, C., Rumble, R., Szoeke, C., Taddei, K., Taddei, T., Trounson, B., Ward, V., Martins, R.
Format: Journal Article
Published: IOS Press 2010
Online Access:http://hdl.handle.net/20.500.11937/31314

Internet

http://hdl.handle.net/20.500.11937/31314

Similar Items